181 – 190 of 207
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
Increased CSF biomarkers of angiogenesis in Parkinson disease.
(
- Contribution to journal › Article
- 2014
-
Mark
Levels of cerebrospinal fluid α-synuclein oligomers are increased in Parkinson's disease with dementia and dementia with Lewy bodies compared to Alzheimer's disease.
(
- Contribution to journal › Article
-
Mark
Accuracy of Brain Amyloid Detection in Clinical Practice Using Cerebrospinal Fluid β-Amyloid 42: A Cross-Validation Study Against Amyloid Positron Emission Tomography.
(
- Contribution to journal › Article
-
Mark
Increased Levels of Hyaluronic Acid in Cerebrospinal Fluid in Patients with Vascular Dementia.
(
- Contribution to journal › Article
-
Mark
Low Levels of Soluble NG2 in Cerebrospinal Fluid from Patients with Dementia with Lewy Bodies.
2014) In Journal of Alzheimer's Disease(
- Contribution to journal › Article
-
Mark
White matter hyperintensities as a confounder in diffusion tensor imaging analysis of elderly cohorts
2014) ISMRM-ESMRMB(
- Contribution to conference › Abstract
- 2013
-
Mark
NG2 cells, a new trail for Alzheimer's disease mechanisms?
(
- Contribution to journal › Article
-
Mark
Proinflammatory cytokines are elevated in serum of patients with multiple system atrophy.
(
- Contribution to journal › Article
-
Mark
Assessment of Global and Regional Diffusion Changes along White Matter Tracts in Parkinsonian Disorders by MR Tractography.
(
- Contribution to journal › Article
-
Mark
Low CSF Levels of Both α-Synuclein and the α-Synuclein Cleaving Enzyme Neurosin in Patients with Synucleinopathy.
(
- Contribution to journal › Article